Xinbao Hao

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling”.

Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling

Cell & Bioscience(2023)10.1186/s13578-023-01137-w

N/A

0DataRank · unranked

23 citations

Zhe Yang, Xinbao Hao, Lauren J. Dandreo, Lily He, Yuxia Zhang +4 more

Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147

Biomedicines(2023)10.3390/biomedicines11072019

N/A

0DataRank · unranked

7 citations

Qi Zhang, Xiaoqing Wu, Siyuan Hao, Xinbao Hao, Elizabeth A. V. Jones +4 more

Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147

Research Square(2023)10.21203/rs.3.rs-2763207/v1

N/A

0DataRank · unranked

3 citations

Qi Zhang, Xiaoqing Wu, Siyuan Hao, Xinbao Hao, Elizabeth A. V. Jones +4 more